Shree Ganesh Bio-Tech (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shree Ganesh Bio-Tech (India) Ltd. on BSE

Load latest

Shree Ganesh Bio-Tech (India) Ltd.

19 Jan 2022

0.89

1.14%

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholding for the Period Ended December 31, 2021

BSE India

Shree Ganesh Biotech (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here

Shree Ganesh Bio-Tech (India) Ltd.

11 Jan 2022

0.89

1.14%

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Updation Of Directors/Company Secretary Of The Company

BSE India

With reference to above subject matter this is to inform you that the Ms. Komal Shukla has already resigned from the post of Company Secretary of the company Ms. Namita Acharya was appointed as Company Secretary of the Company. You are requested to update your record for the information of the shareholders of the company. Thanking You

pdf

Shree Ganesh Bio-Tech (India) Ltd.

06 Jan 2022

0.89

1.14%

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from Satellite Corporate Services Private Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 31st December 2021. This is for your information and records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

01 Jan 2022

0.89

1.14%

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Statement Of Investor Complaints For The Quarter Ended December 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SOMBIR SINGHDesignation :- Any Other

Shree Ganesh Bio-Tech (India) Ltd.

29 Dec 2021

0.89

1.14%

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in terms of Company''s Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from 1st January, 2022 till 48 hours after announcement/declaration of unaudited Financial Results for the quarter ended on 31st December, 2021. The date of Board Meeting shall be intimated to exchange separately. Thanking you.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

29 Dec 2021

0.89

1.14%

Corp. Action

Shree Ganesh Biotech (India) Ltd - 539470 - Reg 42 As Per SEBI LODR Intimation Of …

BSE India

In terms of Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has fixed Friday, February 11, 2022 as the "Record Date", for the purpose of sub- division of Company''s 1 (one) equity shares of face value of Rs. 10/- each into 10(ten) equity shares of face value of Rs 1/-each, subject to the approval of shareholders which is being obtained through Postal Ballot (including e-voting) in accordance with the applicable laws and regulations. You are requested to take the above information on record.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

21 Dec 2021

0.89

1.14%

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Notice Of Postal Ballot Under Section 110 Of …

BSE India

Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015. We enclose herewith copy of Notice of Postal Ballot along with Explanatory Statement, and Calendar of Events for Postal Ballot.. You are requested to take the same on your record. Thanking you,.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

20 Dec 2021

0.89

1.14%

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Outcome Of Board Meeting Held On Today I.E. …

BSE India

Pursuant to Second proviso to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 20th December 2021 at the Registered Office of the Company and transacted the following major businesses: 1 Recommended the proposal of sub- division of Company''s 1 (one) equity shares of face value of Rs. 10/- each into 10(ten) equity shares of face value of Rs 1/-each subject to approval by shareholders. Record date for Split/Sub-division of Nominal Value will be intimated in due course subject to compliance of necessary laws. 2 Recommended alteration of Capital Clause (Clause V) in the Memorandum of Association of the Company, subject to the approval by shareholders. 3 Considered & approved the draft notice of Postal Ballot. Please, take above on your records and oblige us.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

20 Dec 2021

0.89

1.14%

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Outcome Of Meeting Of …

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

10 Dec 2021

0.89

1.14%

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Sub-Division Of Face Value …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2021 ,inter alia, to consider and approve 1. To approve Sub-Division of Face Value of Equity Shares of Rs. 10/- into Rs. 1/- per Equity Share. 2. To change the Clause V - Authorised Capital of Memorandum of Articles according. 3. To approve notice of General Meeting to seek approval for the above-mentioned items as recommended by Board. 4. Any other business as Board deem fit to discuss, with the permission of the Chairman. Please take the above intimation in your records. Thanking You

pdf

Is Shree Ganesh Bio-Tech (India) Ltd. worth buying?

272 Votes:

Buy 73.53%

Sell 8.82%

Hold 17.65%